Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FS Investment Corp IIINONE · Entity 16526 | Director | July 08, 2019 | July 15, 2019 |
| FS Investment Corp IVNONE · Entity 152998 | Director | July 08, 2019 | July 15, 2019 |
| FS KKR Capital CorpFSK · Entity 776 | Director | November 25, 2024 | November 26, 2024 |
| FS KKR Capital Corp. IINONE · Entity 138043 | Director | July 08, 2019 | July 15, 2019 |
| IBERE PHARMACEUTICALSIBER · Entity 141979 | Director · Chief Executive Officer · 10% owner | February 25, 2021 | February 25, 2021 |
| KKR FS Income TrustNONE · Entity 15311 | Director | May 29, 2023 | May 30, 2023 |
| KKR FS Income Trust SelectNONE · Entity 15233 | Director | June 07, 2023 | June 07, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FS Investment Corp III
Report date July 08, 2019 · Filed July 15, 2019
This filing explicitly reported no securities owned.
FS Investment Corp IV
Report date July 08, 2019 · Filed July 15, 2019
This filing explicitly reported no securities owned.
FS KKR Capital Corp
Report date November 25, 2024 · Filed November 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,603 |
Reported balance
After 2024-11-25 transaction · row 1
1 source rowRow 1 · 2024-11-25 · Sale · Disposed 40,885 · Balance 7,603 F1: The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price |
Filing footnotes · ownership attribution and instrument terms
F1: The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price
FS KKR Capital Corp. II
Report date July 08, 2019 · Filed July 15, 2019
This filing explicitly reported no securities owned.
IBERE PHARMACEUTICALS
Report date February 25, 2021 · Filed February 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Ordinary SharesSEC Table II · derivative / convertible security | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2021-02-25 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein. F2: These shares represent Class B ordinary shares held by PIPV Capital LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer and a subsequent share dividend of Class B ordinary shares to the Sponsor. The Class B ordinary shares owned by the Sponsor includes up to 450,000 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the issuer's Registration Statement. F3: These shares are held of record by the Sponsor. The Sponsor is beneficially owned and controlled by the Reporting Person, Lisa Gray, and Zoltan Kerekes, each of whom may be deemed to have beneficial ownership over these shares. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein.
F2: These shares represent Class B ordinary shares held by PIPV Capital LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer and a subsequent share dividend of Class B ordinary shares to the Sponsor. The Class B ordinary shares owned by the Sponsor includes up to 450,000 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the issuer's Registration Statement.
F3: These shares are held of record by the Sponsor. The Sponsor is beneficially owned and controlled by the Reporting Person, Lisa Gray, and Zoltan Kerekes, each of whom may be deemed to have beneficial ownership over these shares. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
KKR FS Income Trust
Report date May 29, 2023 · Filed May 30, 2023
This filing explicitly reported no securities owned.
KKR FS Income Trust Select
Report date June 07, 2023 · Filed June 07, 2023
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 25, 2024 Filed Nov 26, 2024 19:38 UTC | FS KKR Capital Corp FSK · Entity 776 | SaleCommon Stock | 40,885 | $22.01 | $900,034.21 |
DisclosureSEC source: 0001104659-24-123024 · tm2429617-1_4seq1.xml · nonDerivative · entry 1 IMASOGIE OSAGIE O · CIK 0001275878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,603 F1 · price: The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 21:01 UTC | FS KKR Capital Corp FSK · Entity 776 | PurchaseCommon Stock | 39,825 | $22.74 | $905,457.22 |
DisclosureSEC source: 0001387131-21-008417 · imasogie-form4_081121.xml · nonDerivative · entry 1 IMASOGIE OSAGIE O · CIK 0001275878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,488 F1 · balance_after: Effective on June 15, 2020, FS KKR Capital Corp. ("FSK") effected a 4 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:49 UTC | FS KKR Capital Corp FSK · Entity 776 | PurchaseCommon Stock | 18,083 | $5.59 | $101,071.31 |
DisclosureSEC source: 0001387131-20-002602 · ownership.xml · nonDerivative · entry 1 IMASOGIE OSAGIE O · CIK 0001275878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,658 F1 · kind: The purchases were effected in multiple transactions at prices ranging from $5.585 to $5.60, inclusive. The price reported in Column 4 is the weighted average price. The reporting person undertakes to provide, upon request, full information regarding the number of shares purchased in each transaction. Read SEC document |
| November 20, 2019 Filed Nov 20, 2019 22:18 UTC | FS KKR Capital Corp FSK · Entity 776 | PurchaseCommon Stock | 16,575 | $6.04 | $100,113.00 |
DisclosureSEC source: 0001387131-19-008923 · imasogie-form4_112019.xml · nonDerivative · entry 1 IMASOGIE OSAGIE O · CIK 0001275878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,575 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.